Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

13.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.5K
Pharmacovigilance01:19

Pharmacovigilance

2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

219
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
219
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

85
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
85
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

368
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
368
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.4K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LMOD+: A Comprehensive Multimodal Dataset and Benchmark for Developing and Evaluating Multimodal Large Language Models in Ophthalmology.

ACM transactions on computing for healthcare·2026
Same author

Knowledge-guided contextual gene set analysis with large language models.

Bioinformatics (Oxford, England)·2026
Same author

Large Language Models Meet Biomedical Knowledge Graphs for Mechanistically Grounded Therapeutic Prioritization.

ArXiv·2026
Same author

DeepER-Med: Advancing Deep Evidence-Based Research in Medicine Through Agentic AI.

ArXiv·2026
Same author

MedHopQA: A Disease-Centered Multi-Hop Reasoning Benchmark and Evaluation Framework for LLM-Based Biomedical Question Answering.

ArXiv·2026
Same author

Toward Multimodal Conversational AI for Age-Related Macular Degeneration.

ArXiv·2026

Related Experiment Video

Updated: Apr 15, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K

Scaling drug indication curation through crowdsourcing.

Ritu Khare1, John D Burger2, John S Aberdeen2

  • 1National Center for Biotechnology Information (NCBI), 8600 Rockville Pike, Bethesda, MD 20894, USA.

Database : the Journal of Biological Databases and Curation
|March 24, 2015
PubMed
Summary
This summary is machine-generated.

Crowdsourcing drug indication annotation using Amazon Mechanical Turk (MTurk) significantly reduces time and cost compared to expert curation. This approach achieves high accuracy, making biological database curation more efficient.

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.9K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

Related Experiment Videos

Last Updated: Apr 15, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.9K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Pharmacology

Background:

  • Manual curation of biological databases is costly and time-consuming.
  • Existing methods for cataloging drug indications from FDA drug labels require substantial human effort (e.g., LabeledIn took 40+ hours).
  • There is a need for scalable and cost-effective approaches to biological data annotation.

Purpose of the Study:

  • To investigate the feasibility of using crowdsourcing for drug indication annotation.
  • To assess the scalability, cost-effectiveness, and accuracy of crowdsourcing via Amazon Mechanical Turk (MTurk).
  • To develop a simplified task interface for non-expert workers to annotate drug indications.

Main Methods:

  • Transformed expert-curation task into binary judgment Human Intelligence Tasks (HITs) on MTurk.
  • Designed a novel crowdsourcing interface encoding annotation guidelines into user options.
  • Deployed over 3000 HITs across 706 drug labels and collected 18,775 judgments from 74 workers.

Main Results:

  • Collected data within 8 hours of posting HITs.
  • Achieved an aggregated accuracy of 96% on control HITs.
  • Obtained results at a cost of $1.75 per drug label, demonstrating significant cost and time savings.

Conclusions:

  • Crowdsourcing drug indication annotation is a feasible and efficient alternative to expert curation.
  • The proposed method achieves accuracy comparable to domain experts.
  • This approach offers substantial cost and time savings for biological database curation.